Chikungunya Fever - Pipeline Review, H2 2017

SKU ID :GMD-10635729 | Published Date: 31-Oct-2017 | No. of pages: 103
Table of Contents Table of Contents 2 List of Tables 5 List of Figures 5 Introduction 7 Global Markets Direct Report Coverage 7 Chikungunya Fever - Overview 8 Chikungunya Fever - Therapeutics Development 9 Pipeline Overview 9 Pipeline by Companies 10 Pipeline by Universities/Institutes 13 Products under Development by Companies 14 Products under Development by Universities/Institutes 16 Chikungunya Fever - Therapeutics Assessment 17 Assessment by Target 17 Assessment by Mechanism of Action 19 Assessment by Route of Administration 21 Assessment by Molecule Type 23 Chikungunya Fever - Companies Involved in Therapeutics Development 25 Abivax SA 25 Arno Therapeutics Inc 25 Bharat Biotech International Ltd 25 Ennaid Therapeutics LLC 26 Etubics Corp 26 Hawaii Biotech Inc 27 Indian Immunologicals Ltd 27 Inovio Pharmaceuticals Inc 27 Integral Molecular Inc 28 Integrated BioTherapeutics Inc 28 Moderna Therapeutics Inc 28 Mymetics Corp 29 Nanotherapeutics Inc 29 Paradigm Biopharmaceuticals Ltd 30 PaxVax Inc 30 Profectus BioSciences Inc 30 Shionogi & Co Ltd 31 Takeda Pharmaceutical Co Ltd 31 Themis Bioscience GmbH 32 Valneva SE 32 Vaxart Inc 33 Chikungunya Fever - Drug Profiles 34 (chikungunya + Zika) (bivalent) vaccine - Drug Profile 34 ABX-311 - Drug Profile 35 AR-12 - Drug Profile 36 BBV-87 - Drug Profile 39 chikungunya (viral like particles) vaccine - Drug Profile 40 chikungunya (virus like particle) vaccine - Drug Profile 41 chikungunya vaccine - Drug Profile 42 chikungunya vaccine - Drug Profile 44 chikungunya vaccine - Drug Profile 45 chikungunya vaccine - Drug Profile 46 chikungunya vaccine - Drug Profile 47 chikungunya vaccine - Drug Profile 48 chikungunya vaccine - Drug Profile 49 chikungunya vaccine - Drug Profile 50 chikungunya vaccine - Drug Profile 51 chikungunya vaccine - Drug Profile 52 chikungunya vaccine - Drug Profile 53 chikungunya vaccine - Drug Profile 54 chikungunya vaccine - Drug Profile 55 chikungunya vaccine - Drug Profile 56 Gene Therapy for Chikungunya - Drug Profile 57 HSRx-431 - Drug Profile 58 IMCKV-063 - Drug Profile 59 Monoclonal Antibodies for Chikungunya - Drug Profile 60 Monoclonal Antibodies for Equine Encephalitis and Chikungunya - Drug Profile 61 Monoclonal Antibodies to Inhibit CHIKV E2 for Chikungunya - Drug Profile 62 mRNA-1388 - Drug Profile 63 MV-CHIK - Drug Profile 64 pentosan polysulfate sodium - Drug Profile 67 Peptides for Infectious Diseases - Drug Profile 71 SCV-305 - Drug Profile 72 Small Molecule to Inhibit NS2 and NS3 for Chikungunya - Drug Profile 73 Small Molecule to Inhibit NS4 for Chikungunya Fever - Drug Profile 74 Small Molecules for Chikungunya - Drug Profile 75 Small Molecules for Chikungunya - Drug Profile 76 Small Molecules for Chikungunya Fever - Drug Profile 77 Small Molecules for Chikungunya Fever - Drug Profile 78 Small Molecules for Infectious Disease - Drug Profile 79 SVIR-001 - Drug Profile 80 Synthetic Peptides for Chikungunya - Drug Profile 81 TAK-507 - Drug Profile 82 Tatbeclin-1 - Drug Profile 83 VLA-1553 - Drug Profile 84 Chikungunya Fever - Dormant Projects 85 Chikungunya Fever - Product Development Milestones 86 Featured News & Press Releases 86 Appendix 99 Methodology 99 Coverage 99 Secondary Research 99 Primary Research 99 Expert Panel Validation 99 Contact Us 99 Disclaimer 100
List of Tables Number of Products under Development for Chikungunya Fever, H2 2017 Number of Products under Development by Companies, H2 2017 Number of Products under Development by Companies, H2 2017 (Contd..1), H2 2017 Number of Products under Development by Universities/Institutes, H2 2017 Products under Development by Companies, H2 2017 Products under Development by Companies, H2 2017 (Contd..1), H2 2017 Products under Development by Universities/Institutes, H2 2017 Number of Products by Stage and Target, H2 2017 Number of Products by Stage and Mechanism of Action, H2 2017 Number of Products by Stage and Route of Administration, H2 2017 Number of Products by Stage and Molecule Type, H2 2017 Chikungunya Fever - Pipeline by Abivax SA, H2 2017 Chikungunya Fever - Pipeline by Arno Therapeutics Inc, H2 2017 Chikungunya Fever - Pipeline by Bharat Biotech International Ltd, H2 2017 Chikungunya Fever - Pipeline by Ennaid Therapeutics LLC, H2 2017 Chikungunya Fever - Pipeline by Etubics Corp, H2 2017 Chikungunya Fever - Pipeline by Hawaii Biotech Inc, H2 2017 Chikungunya Fever - Pipeline by Indian Immunologicals Ltd, H2 2017 Chikungunya Fever - Pipeline by Inovio Pharmaceuticals Inc, H2 2017 Chikungunya Fever - Pipeline by Integral Molecular Inc, H2 2017 Chikungunya Fever - Pipeline by Integrated BioTherapeutics Inc, H2 2017 Chikungunya Fever - Pipeline by Moderna Therapeutics Inc, H2 2017 Chikungunya Fever - Pipeline by Mymetics Corp, H2 2017 Chikungunya Fever - Pipeline by Nanotherapeutics Inc, H2 2017 Chikungunya Fever - Pipeline by Paradigm Biopharmaceuticals Ltd, H2 2017 Chikungunya Fever - Pipeline by PaxVax Inc, H2 2017 Chikungunya Fever - Pipeline by Profectus BioSciences Inc, H2 2017 Chikungunya Fever - Pipeline by Shionogi & Co Ltd, H2 2017 Chikungunya Fever - Pipeline by Takeda Pharmaceutical Co Ltd, H2 2017 Chikungunya Fever - Pipeline by Themis Bioscience GmbH, H2 2017 Chikungunya Fever - Pipeline by Valneva SE, H2 2017 Chikungunya Fever - Pipeline by Vaxart Inc, H2 2017 Chikungunya Fever - Dormant Projects, H2 2017 List of Figures Number of Products under Development for Chikungunya Fever, H2 2017 Number of Products under Development by Companies, H2 2017 Number of Products under Development by Universities/Institutes, H2 2017 Number of Products by Top 10 Targets, H2 2017 Number of Products by Stage and Top 10 Targets, H2 2017 Number of Products by Top 10 Mechanism of Actions, H2 2017 Number of Products by Stage and Top 10 Mechanism of Actions, H2 2017 Number of Products by Routes of Administration, H2 2017 Number of Products by Stage and Routes of Administration, H2 2017 Number of Products by Top 10 Molecule Types, H2 2017 Number of Products by Stage and Top 10 Molecule Types, H2 2017
Abivax SA Arno Therapeutics Inc Bharat Biotech International Ltd Ennaid Therapeutics LLC Etubics Corp Hawaii Biotech Inc Indian Immunologicals Ltd Inovio Pharmaceuticals Inc Integral Molecular Inc Integrated BioTherapeutics Inc Moderna Therapeutics Inc Mymetics Corp Nanotherapeutics Inc Paradigm Biopharmaceuticals Ltd PaxVax Inc Profectus BioSciences Inc Shionogi & Co Ltd Takeda Pharmaceutical Co Ltd Themis Bioscience GmbH Valneva SE Vaxart Inc
  • PRICE
  • $2000
    $6000

Our Clients